Pharmacokinetic Interaction Between Amprenavir/Ritonavir and FosAmprenavir on Cyclosporine in Two Patients With Human Immunodeficiency Virus Infection Undergoing Orthotopic Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 4, 2006, Pages 1138-1140

  Guaraldi, G ^a   Cocchi, S ^a   Codeluppi, M ^a   Di Benedetto, F ^a   Bonora, S ^b   Motta, A ^a   Luzi, K ^a   Pecorari, M ^a   Gennari, W ^a   Masetti, M ^a   Gerunda, G E ^a   Esposito, R ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; AMPRENAVIR PHOSPHATE; CYCLOSPORIN A; ENFUVIRTIDE; LAMIVUDINE; RITONAVIR; STEROID; TENOFOVIR;

ACUTE GRAFT REJECTION; ADULT; ANAMNESIS; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TOXICITY;

ADULT; ANTI-HIV AGENTS; CARBAMATES; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PHOSPHORIC ACID ESTERS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 33744548433     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.02.013     Document Type: Article

References (7)

1. Osmond D.H., Charlebois E., Sheppard H.W., et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 167 (1993) 66
2. Ragni M.V., Belle S.H., Im K., et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 188 (2003) 1412
3. Neff G.W., Bonham A., Tzakis A.G., et al. Orthotopic liver transplantation in patients with HIV and end-stage liver disease. Liver Transpl 9 (2003) 239
4. Jain A.B., Venkataramanan R., Eghtesad B., et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl 9 (2003) 954
5. Vincent S.H., Karanam B.V., Painter S.K., et al. In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes. identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch Biochem Biophys 294 (1992) 454
6. Sheikh A.M., Wolf D.C., Lebovics E., et al. Concomitant human immunodeficiency virus protease inhibitors therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation 68 (1999) 307
7. Furlan V., and Taburet A.M. Drug interactions with antiretroviral agents. (in French). Therapie 56 (2001) 267